Clinical behavior and outcomes of BRCA-mutated breast cancer in young patients according to type of BRCA mutation and hormone receptor status: Results from an international cohort study

被引：0

作者：

Lambertini, Matteo ^{[1
]}

Ceppi, Marcello ^{[1
]}

Hamy, Anne-Sophie ^{[2
]}

Caron, Olivier ^{[3
]}

Poorvu, Philip D. ^{[4
]}

Carrasco, Estela ^{[5
]}

Grinshpun, Albert ^{[6
]}

Punie, Kevin ^{[7
]}

Rousset-Jablonski, Christine ^{[8
]}

Ferrari, Alberta ^{[9
]}

Paluch-Shimon, Shani ^{[10
]}

Toss, Angela ^{[11
]}

Senechal, Claire ^{[12
]}

Puglisi, Fabio ^{[13
]}

Pogoda, Katarzyna ^{[14
]}

Perez-Fidalgo, Jose Alejandro ^{[15
]}

De Marchis, Laura ^{[16
]}

Ponzone, Riccardo ^{[17
]}

Livraghi, Luca ^{[18
]}

Estevez-Diz, Maria Del Pilar ^{[19
]}

Villarreal-Garza, Cynthia ^{[20
]}

Dieci, Maria Vittoria ^{[21
]}

Clatot, Florian ^{[22
]}

Duhoux, Francois P. ^{[23
]}

Graffeo, Rossella ^{[24
]}

Teixeira, Luis ^{[25
]}

Cordoba, Octavi ^{[26
]}

Sonnenblick, Amir ^{[27
]}

Ferreira, Arlindo R. ^{[28
]}

Partridge, Ann H. ^{[4
]}

Di Meglio, Antonio ^{[3
]}

Saule, Claire ^{[29
]}

Peccatori, Fedro A. ^{[30
]}

Bruzzone, Marco ^{[1
]}

Del Mastro, Lucia ^{[1
]}

Ameye, Lieveke ^{[31
,32
]}

Balmana, Judith ^{[5
]}

Azim, Hatem A., Jr. ^{[33
]}

机构：

[1] Univ Genoa, IRCCS Osped Policlin San Martino, Genoa, Italy

[2] Inst Curie, Parisq, Italy

[3] Inst Gustave Roussy, Villejuif, France

[4] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA

[5] Hosp Univ Vall dHebron Barcelona Hosp Campus, Vall dHebron Inst Oncol VHIO, Barcelona, Spain

[6] Hadassah Hebrew Univ Med Ctr, Jerusalem, Israel

[7] Univ Hosp Leuven, Leuven Canc Inst, Leuven, Belgium

[8] Ctr Leon Berard, Lyon, France

[9] Univ Pavia, Fdn IRCCS Policlin San Matteo, Pavia, Italy

[10] Shaare Zedek Med Ctr, Jerusalem, Israel

[11] Azienda Osped Univ Policlin Modena, Modena, Italy

[12] Bergonie Inst, Bordeaux, France

[13] Ctr Riferimento Oncol Avano CRO IRCCS, Aviano, Italy

[14] Maria Sklodowska Curie Natl Res Inst Oncol, Warsaw, Poland

[15] INCLIVA Univ Hosp Valencia, Valencia, Spain

[16] Univ Roma La Sapienza, Rome, Italy

[17] FPO IRCCS, Candiolo Canc Inst, Candiolo, Italy

[18] ASST Papa Giovanni XXIII, Bergamo, Italy

[19] Univ Sao Paulo, Fac Med, Inst Canc Estado Sao Paulo, Sao Paulo, Brazil

[20] Tecnol Monterrey, Pital Zambrano Hell, San Pedro Garza Garcia, Mexico

[21] Univ Padua, Padua, Italy

[22] Ctr Henri Becquerel, Rouen, France

[23] UCLouvain, Clin Univ St Luc, Brussels, Belgium

[24] Oncol Inst Southern Switzerland, Bellinzona, Switzerland

[25] Univ Paris, St Louis Hosp, Paris, France

[26] Hosp Univ Son Espases, Palma De Mallorca, Spain

[27] Tel Aviv Sourasky Med Ctr, Tel Aviv, Israel

[28] Champalimaud Fdn, Champalimaud Clin Ctr, Lisbon, Portugal

[29] Inst Curie, Paris, France

[30] European Inst Oncol IRCCS, Milan, Italy

[31] Inst Jules Bordet, Brussels, Belgium

[32] Univ Libre Bruxelles ULB, Brussels, Belgium

[33] Tecnol Monterrey, Hosp Zambrano Hell, San Pedro Garza Garcia, Mexico

来源：

CANCER RESEARCH | 2021年 / 81卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

PD10-06

引用

页数：2

共 50 条

[41] Use and safety of assisted reproductive technology in young BRCA carriers with a pregnancy after treatment for breast cancer: results from an international cohort study
Magaton, I. M.
Blandeaux, E.
Hamy, A. S.
Linn, S.
Bernstein-Molho, R.
Peccatori, F. A.
Ferrari, A.
Agostinetto, E.
Venturelli, M.
Vaz-Duarte-Luis, I. M.
Rodriguez-Wallberg, K. A.
Demeestere, I.
Azim, H. A., Jr.
Partridge, A. H.
Lambertini, M.
HUMAN REPRODUCTION, 2024, 39
[42] Outcomes after breast cancer in an ethnically diverse cohort of high-risk patients: Differences in survival based on BRCA1/BRCA2 mutation status
Nanda, R.
Huo, D.
Cook, M.
Chen, L.
Hope, K.
Cummings, S.
Olopade, O. I.
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
[43] Niraparib efficacy and safety in patients with BRCA-mutated (BRCAm) ovarian cancer: results from three phase 3 niraparib trials
Gonzalez-Martin, Antonio
Grabowski, Jacek
Matulonis, Ursula
Korach, Jacob
Mirza, Mansoor
Moore, Kathleen
Gupta, Divya
Lechpammer, Stanislav
Monk, Bradley J.
ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) : 120 - 120
[44] Reproductive and Hormonal Factors, and Ovarian Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Results from the International BRCA1/2 Carrier Cohort Study
Antoniou, Antonis C.
Rookus, Matti
Andrieu, Nadine
Brohet, Richard
Chang-Claude, Jenny
Peock, Susan
Cook, Margaret
Evans, D. Gareth
Eeles, Rosalind
Nogues, Catherine
Faivre, Laurence
Gesta, Paul
van Leeuwen, Flora E.
Ausems, Margreet G. E. M.
Sorio, Ana
Caldes, Trinidad
Simard, Jacques
Lubinski, Jan
Gerdes, Anne-Marie
Olah, Edith
Fuerhauser, Christine
Olsson, Hakan
Arver, Brita
Radice, Paolo
Easton, Douglas F.
Goldgarl, David E.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (02) : 601 - 610
[45] Concordance of Hormone Receptor Status and BRCA1/2 Mutation Among Women With Synchronous Bilateral Breast Cancer
Huang, Liang
Liu, Qi
Lang, Guan-Tian
Cao, A-Yong
Shao, Zhi-Ming
FRONTIERS IN ONCOLOGY, 2020, 10
[46] Efficacy of adjuvant chemotherapy according to hormone receptor status in young breast cancer patients
van der Hage, J.
van de Velde, C. J. H.
Therasse, P.
van de Vijver, M. J.
EJC SUPPLEMENTS, 2004, 2 (03): : 72 - 72
[47] Phase II study of olaparib (O) and durvalumab (D) (MEDIOLA): Updated results in patients (pts) with germline BRCA-mutated (gBRCAm) metastatic breast cancer (MBC)
Domchek, S.
Postel-Vinay, S.
Im, S-A.
Park, Y. H.
Delord, J-P.
Italiano, A.
Alexandre, J.
You, B.
Bastian, S.
Krebs, M. G.
Wang, D.
Waqar, S.
Lanasa, M.
Angell, H. K.
Lai, Z.
Gresty, C.
Opincar, L. M.
Herbolsheimer, P.
Kaufman, B.
ANNALS OF ONCOLOGY, 2019, 30 : 477 - 477
[48] Breast Cancer Prognosis in BRCA1 and BRCA2 Mutation Carriers: An International Prospective Breast Cancer Family Registry Population-Based Cohort Study
Goodwin, Pamela J.
Phillips, Kelly-Anne
West, Dee W.
Ennis, Marguerite
Hopper, John L.
John, Esther M.
O'Malley, Frances P.
Milne, Roger L.
Andrulis, Irene L.
Friedlander, Michael L.
Southey, Melissa C.
Apicella, Carmel
Giles, Graham G.
Longacre, Teri A.
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (01) : 19 - 26
[49] Survival outcomes of BRCA1/BRCA2 mutated breast cancers: Study from a tertiary care cancer centre in India
Nithin, S. G.
Gogia, Ajay
Pramanik, Raja
Sagiraju, Hari Krishna Raju
Deo, S. V. S.
Sharma, D. N.
Batra, Atul
Jha, Akash
Mathur, Sandeep
Gupta, Ritu
Prasad, Chandra Prakash
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[50] Efficacy and safety of talazoparib in Japanese patients with germline BRCA-mutated locally advanced or metastatic breast cancer: results of the phase 1 dose-expansion study
Haruru Kotani
Norikazu Masuda
Toshinari Yamashita
Yoichi Naito
Tetsuhiko Taira
Kenichi Inoue
Masato Takahashi
Kan Yonemori
Shigeyuki Toyoizumi
Yuko Mori
Takashi Nagasawa
Natsuki Hori
Hiroji Iwata
Breast Cancer, 2022, 29 : 1088 - 1098

← 1 2 3 4 5 →